Recursion Pharmaceuticals (RXRX) Insider Trading & Ownership $7.48 -0.10 (-1.32%) (As of 11:52 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recursion Pharmaceuticals (NASDAQ:RXRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.75%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$10.02 M Get RXRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Recursion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RXRX Insider Buying and Selling by Quarter Ad Brownstone ResearchMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Recursion Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/13/2024Michael SecoraCFOSell15,000$7.66$114,900.00 11/12/2024Blake BorgesonDirectorSell11,447$7.64$87,455.08 10/29/2024Blake BorgesonDirectorSell11,447$6.72$76,923.84 10/24/2024Tina MarriottCOOSell6,000$6.31$37,860.00 10/15/2024Blake BorgesonDirectorSell11,447$6.67$76,351.49 10/8/2024Michael SecoraCFOSell15,000$6.32$94,800.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/2/2024Christopher GibsonCEOSell20,000$6.16$123,200.00 10/1/2024Blake BorgesonDirectorSell11,447$6.22$71,200.34 9/26/2024Tina MarriottCOOSell6,000$7.00$42,000.00 9/17/2024Blake BorgesonDirectorSell11,447$6.84$78,297.48 9/10/2024Michael SecoraCFOSell15,000$6.17$92,550.00 9/4/2024Christopher GibsonCEOSell20,000$6.04$120,800.00 9/3/2024Blake BorgesonDirectorSell11,447$6.27$71,772.69 8/29/2024Tina MarriottCOOSell6,000$7.56$45,360.00 8/20/2024Blake BorgesonDirectorSell11,447$7.12$81,502.64 8/13/2024Michael SecoraCFOSell15,000$6.35$95,250.00 8/7/2024Christopher GibsonCEOSell30,000$7.10$213,000.00 8/6/2024Blake BorgesonDirectorSell11,447$6.82$78,068.54 7/25/2024Tina MarriottCOOSell6,000$8.13$48,780.00 7/23/2024Blake BorgesonDirectorSell11,447$8.48$97,070.56 7/10/2024Christopher GibsonCEOSell50,000$7.48$374,000.00 7/9/2024Blake BorgesonDirectorSell11,447$7.32$83,792.04 7/9/2024Michael SecoraCFOSell15,000$7.32$109,800.00 6/27/2024Tina MarriottCOOSell6,000$7.21$43,260.00 6/25/2024Blake BorgesonDirectorSell11,447$9.51$108,860.97 6/13/2024Michael SecoraCFOSell15,000$9.32$139,800.00 6/11/2024Blake BorgesonDirectorSell11,447$8.45$96,727.15 6/5/2024Christopher GibsonCEOSell50,000$8.42$421,000.00 5/30/2024Tina MarriottCOOSell3,000$8.78$26,340.00 5/28/2024Blake BorgesonDirectorSell11,447$9.17$104,968.99 5/1/2024Christopher GibsonCEOSell50,000$7.73$386,500.00 4/30/2024Blake BorgesonDirectorSell11,447$7.95$91,003.65 4/25/2024Tina MarriottCOOSell3,000$7.67$23,010.00 4/17/2024Michael SecoraCFOSell23,124$7.58$175,279.92 4/16/2024Blake BorgesonDirectorSell11,447$7.66$87,684.02 4/3/2024Christopher GibsonCEOSell40,000$8.84$353,600.00 4/2/2024Blake BorgesonDirectorSell11,447$8.82$100,962.54 3/28/2024Christopher GibsonCEOSell40,000$10.10$404,000.00 3/21/2024Tina MarriottCOOSell8,000$10.75$86,000.00 3/19/2024Blake BorgesonDirectorSell20,054$10.79$216,382.66 Is the Trump/Musk duo good for shares of TSLA? (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here.3/13/2024Michael SecoraCFOSell25,000$11.03$275,750.00 3/6/2024Christopher GibsonCEOSell36,319$11.86$430,743.34 3/5/2024Blake BorgesonDirectorSell20,054$12.06$241,851.24 2/22/2024Tina MarriottCOOSell8,000$14.89$119,120.00 2/20/2024Blake BorgesonDirectorSell20,054$12.32$247,065.28 2/13/2024Michael SecoraCFOSell25,000$9.86$246,500.00 2/7/2024Christopher GibsonCEOSell48,272$9.22$445,067.84 2/6/2024Blake BorgesonDirectorSell11,447$9.30$106,457.10 1/25/2024Tina Marriott LarsonCOOSell8,000$10.35$82,800.00 1/23/2024Blake BorgesonDirectorSell20,054$10.58$212,171.32 1/16/2024Michael SecoraCFOSell25,000$10.45$261,250.00 1/16/2024Shafique ViraniInsiderSell18,000$10.93$196,740.00 1/9/2024Dean Y LiDirectorSell29,000$13.66$396,140.00 1/3/2024Christopher GibsonCEOSell30,853$9.49$292,794.97 12/26/2023Blake BorgesonDirectorSell20,054$10.63$213,174.02 12/15/2023Shafique ViraniInsiderSell18,000$9.60$172,800.00 12/14/2023Zavain DarDirectorSell20,141$9.00$181,269.00 12/12/2023Blake BorgesonDirectorSell11,447$7.40$84,707.80 12/12/2023Michael SecoraCFOSell25,000$7.39$184,750.00 12/6/2023Christopher GibsonCEOSell59,829$7.49$448,119.21 (Data available from 1/1/2013 forward) RXRX Insider Trading Activity - Frequently Asked Questions Who is on Recursion Pharmaceuticals's Insider Roster? The list of insiders at Recursion Pharmaceuticals includes Blake Borgeson, Christopher Gibson, Dean Y Li, Michael Secora, Mubadala Investment Co Pjsc, Shafique Virani, Terry-Ann Burrell, Tina Marriott, Tina Marriott Larson, and Zavain Dar. Learn more on insiders at RXRX. What percentage of Recursion Pharmaceuticals stock is owned by insiders? 15.75% of Recursion Pharmaceuticals stock is owned by insiders. Learn more on RXRX's insider holdings. Which Recursion Pharmaceuticals insiders have been buying company stock? The following insider purchased RXRX shares in the last 24 months: Mubadala Investment Co Pjsc ($4,440,853.30). How much insider buying is happening at Recursion Pharmaceuticals? Insiders have purchased a total of 581,017 RXRX shares in the last 24 months for a total of $4,440,853.30 bought. Which Recursion Pharmaceuticals insiders have been selling company stock? The following insiders have sold RXRX shares in the last 24 months: Blake Borgeson ($4,812,836.07), Christopher Gibson ($7,809,657.37), Dean Y Li ($396,140.00), Michael Secora ($3,154,129.92), Shafique Virani ($2,019,258.38), Terry-Ann Burrell ($104,182.25), Tina Marriott ($471,730.00), Tina Marriott Larson ($515,150.00), and Zavain Dar ($181,269.00). How much insider selling is happening at Recursion Pharmaceuticals? Insiders have sold a total of 2,210,916 Recursion Pharmaceuticals shares in the last 24 months for a total of $19,464,352.99 sold. Recursion Pharmaceuticals Key ExecutivesDr. Christopher C. Gibson Ph.D. (Age 41)Co-Founder, CEO & Director Compensation: $806.72kMs. Tina Marriott Larson (Age 49)COO & President Compensation: $702.24kDr. Blake C. Borgeson Ph.D. (Age 42)Co-Founder & Director Compensation: $40kDr. Michael Secora Ph.D. (Age 41)Chief Financial Officer Compensation: $629.78kDr. David J. Mauro M.D. (Age 59)Ph.D., Chief Medical Officer Compensation: $674.74kKevin LeggatVice President of Finance & AccountingMr. Benjamin Mabey M.S. (Age 41)Chief Technology Officer Mr. Jared AllenbachSenior Director of Investor RelationsMr. Nathan HatfieldChief Legal Officer & General CounselMr. Ryan KellyChief Communications Officer More Insider Trading Tools from MarketBeat Related Companies Nuvalent Insider Buying Elanco Animal Health Insider Buying Lantheus Insider Buying Blueprint Medicines Insider Buying Cytokinetics Insider Buying Viking Therapeutics Insider Buying Krystal Biotech Insider Buying TG Therapeutics Insider Buying Crinetics Pharmaceuticals Insider Buying Arcellx Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in Buybacks This page (NASDAQ:RXRX) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recursion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
